Cargando…

Inhibition of airway remodeling and inflammatory response by Icariin in asthma

BACKGROUND: Icariin (ICA) is the major active ingredient extracted from Chinese herbal medicine Epimedium, which has the effects of improving cardiovascular function, inducing tumor cell differentiation and increasing bone formation. It is still rarely reported that ICA can exert its therapeutic pot...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Lingli, Li, Lulu, Zhang, Hongying, Li, Qiuping, Jiang, Shan, Qiu, Jian, Sun, Jing, Dong, Jingcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862818/
https://www.ncbi.nlm.nih.gov/pubmed/31744482
http://dx.doi.org/10.1186/s12906-019-2743-x
_version_ 1783471639293329408
author Hu, Lingli
Li, Lulu
Zhang, Hongying
Li, Qiuping
Jiang, Shan
Qiu, Jian
Sun, Jing
Dong, Jingcheng
author_facet Hu, Lingli
Li, Lulu
Zhang, Hongying
Li, Qiuping
Jiang, Shan
Qiu, Jian
Sun, Jing
Dong, Jingcheng
author_sort Hu, Lingli
collection PubMed
description BACKGROUND: Icariin (ICA) is the major active ingredient extracted from Chinese herbal medicine Epimedium, which has the effects of improving cardiovascular function, inducing tumor cell differentiation and increasing bone formation. It is still rarely reported that ICA can exert its therapeutic potential in asthma via anti-airway remodeling. The point of the study was to estimate the role of ICA in anti-. airway remodeling and its possible mechanism of action in a mouse ovalbumin. (OVA)-induced asthma model. METHODS: Hematoxylin and Eosin Staining were performed for measuring airway remodeling related indicators. ELISA, Western blot and Immunohistochemistr-. y (IHC) were used for analyzing the level of protein. RT-PCR was used for analyzing the level of mRNA. RESULTS: On days 1 and 8, mice were sensitized to OVA by intraperitoneal injection. From day 16 to day 43, previously sensitized mice were exposed to OVA once daily by nebulizer. Interventions were performed orally with ICA (ICA low, medium and high dose groups) or dexamethasone 1 h prior to each OVA exposure. ICA improves pulmonary function, attenuates pulmonary inflammation and airway remodeling in mice exposed to OVA. Histological and Western blot analysis of the lungs show that ICA suppressed transforming growth factor beta 1 and vascular endothelial growth factor expression. Increase in interleukin 13 and endothelin-1 in serum and bronchoalveolar lavage fluid in OVA-induced asthmatic mice are also decreased by ICA. ICA attenuates airway smooth muscle cell proliferation, as well as key factors in the MAPK/Erk pathway. CONCLUSIONS: The fact that ICA can alleviate OVA-induced asthma at least partly through inhibition of ASMC proliferation via MAPK/Erk pathway provides a solid theoretical basis for ICA as a replacement therapy for asthma. These data reveal the underlying reasons of the use of ICA-rich herbs in Traditional Chinese Medicine to achieve good results in treating asthma.
format Online
Article
Text
id pubmed-6862818
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68628182019-12-11 Inhibition of airway remodeling and inflammatory response by Icariin in asthma Hu, Lingli Li, Lulu Zhang, Hongying Li, Qiuping Jiang, Shan Qiu, Jian Sun, Jing Dong, Jingcheng BMC Complement Altern Med Research Article BACKGROUND: Icariin (ICA) is the major active ingredient extracted from Chinese herbal medicine Epimedium, which has the effects of improving cardiovascular function, inducing tumor cell differentiation and increasing bone formation. It is still rarely reported that ICA can exert its therapeutic potential in asthma via anti-airway remodeling. The point of the study was to estimate the role of ICA in anti-. airway remodeling and its possible mechanism of action in a mouse ovalbumin. (OVA)-induced asthma model. METHODS: Hematoxylin and Eosin Staining were performed for measuring airway remodeling related indicators. ELISA, Western blot and Immunohistochemistr-. y (IHC) were used for analyzing the level of protein. RT-PCR was used for analyzing the level of mRNA. RESULTS: On days 1 and 8, mice were sensitized to OVA by intraperitoneal injection. From day 16 to day 43, previously sensitized mice were exposed to OVA once daily by nebulizer. Interventions were performed orally with ICA (ICA low, medium and high dose groups) or dexamethasone 1 h prior to each OVA exposure. ICA improves pulmonary function, attenuates pulmonary inflammation and airway remodeling in mice exposed to OVA. Histological and Western blot analysis of the lungs show that ICA suppressed transforming growth factor beta 1 and vascular endothelial growth factor expression. Increase in interleukin 13 and endothelin-1 in serum and bronchoalveolar lavage fluid in OVA-induced asthmatic mice are also decreased by ICA. ICA attenuates airway smooth muscle cell proliferation, as well as key factors in the MAPK/Erk pathway. CONCLUSIONS: The fact that ICA can alleviate OVA-induced asthma at least partly through inhibition of ASMC proliferation via MAPK/Erk pathway provides a solid theoretical basis for ICA as a replacement therapy for asthma. These data reveal the underlying reasons of the use of ICA-rich herbs in Traditional Chinese Medicine to achieve good results in treating asthma. BioMed Central 2019-11-19 /pmc/articles/PMC6862818/ /pubmed/31744482 http://dx.doi.org/10.1186/s12906-019-2743-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Hu, Lingli
Li, Lulu
Zhang, Hongying
Li, Qiuping
Jiang, Shan
Qiu, Jian
Sun, Jing
Dong, Jingcheng
Inhibition of airway remodeling and inflammatory response by Icariin in asthma
title Inhibition of airway remodeling and inflammatory response by Icariin in asthma
title_full Inhibition of airway remodeling and inflammatory response by Icariin in asthma
title_fullStr Inhibition of airway remodeling and inflammatory response by Icariin in asthma
title_full_unstemmed Inhibition of airway remodeling and inflammatory response by Icariin in asthma
title_short Inhibition of airway remodeling and inflammatory response by Icariin in asthma
title_sort inhibition of airway remodeling and inflammatory response by icariin in asthma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862818/
https://www.ncbi.nlm.nih.gov/pubmed/31744482
http://dx.doi.org/10.1186/s12906-019-2743-x
work_keys_str_mv AT hulingli inhibitionofairwayremodelingandinflammatoryresponsebyicariininasthma
AT lilulu inhibitionofairwayremodelingandinflammatoryresponsebyicariininasthma
AT zhanghongying inhibitionofairwayremodelingandinflammatoryresponsebyicariininasthma
AT liqiuping inhibitionofairwayremodelingandinflammatoryresponsebyicariininasthma
AT jiangshan inhibitionofairwayremodelingandinflammatoryresponsebyicariininasthma
AT qiujian inhibitionofairwayremodelingandinflammatoryresponsebyicariininasthma
AT sunjing inhibitionofairwayremodelingandinflammatoryresponsebyicariininasthma
AT dongjingcheng inhibitionofairwayremodelingandinflammatoryresponsebyicariininasthma